These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19258226)
1. [Hand-foot syndrome and sorafenib]. Milano G; Mortier L; Digue L; Desmedt E; Ravaud A Bull Cancer; 2009 Feb; 96(2):191-7. PubMed ID: 19258226 [TBL] [Abstract][Full Text] [Related]
2. [Hand-foot syndrome after administration of tyrosinkinase inhibitors]. Bednaríková D; Kocák I Klin Onkol; 2010; 23(5):300-5. PubMed ID: 21061680 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553 [TBL] [Abstract][Full Text] [Related]
4. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy. Yang CH; Lin WC; Chuang CK; Chang YC; Pang ST; Lin YC; Kuo TT; Hsieh JJ; Chang JW Br J Dermatol; 2008 Mar; 158(3):592-6. PubMed ID: 18070211 [TBL] [Abstract][Full Text] [Related]
7. Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction. Jain L; Gardner ER; Figg WD; Chernick MS; Kong HH Pharmacotherapy; 2010 Jan; 30(1):52-6. PubMed ID: 20030473 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib. McLellan B; Kerr H Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797 [TBL] [Abstract][Full Text] [Related]
9. Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Lacouture ME; Reilly LM; Gerami P; Guitart J Ann Oncol; 2008 Nov; 19(11):1955-61. PubMed ID: 18550575 [TBL] [Abstract][Full Text] [Related]
10. Management of tyrosine kinase inhibitor-induced hand-foot skin reaction: viewpoints from the medical oncologist, dermatologist, and oncology nurse. Manchen E; Robert C; Porta C J Support Oncol; 2011; 9(1):13-23. PubMed ID: 21465734 [TBL] [Abstract][Full Text] [Related]
11. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Lipworth AD; Robert C; Zhu AX Oncology; 2009; 77(5):257-71. PubMed ID: 19923864 [TBL] [Abstract][Full Text] [Related]
12. Reader seeks clarification on hand-foot skin reaction. Clark M Clin J Oncol Nurs; 2008 Jun; 12(3):395; author reply 395. PubMed ID: 18564457 [No Abstract] [Full Text] [Related]